Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis

BACKGROUND: About 3·7 billion doses of ivermectin have been distributed in mass drug administration (MDA) campaigns globally over the past 30 years. At 10−100 times higher than current human doses, ivermectin is a known teratogen in mammals. During these campaigns with recommended doses, pregnant wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolas, Patricia, Maia, Marta F, Bassat, Quique, Kobylinski, Kevin C, Monteiro, Wuelton, Rabinovich, N Regina, Menéndez, Clara, Bardají, Azucena, Chaccour, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613514/
https://www.ncbi.nlm.nih.gov/pubmed/31839144
http://dx.doi.org/10.1016/S2214-109X(19)30453-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613514/
https://www.ncbi.nlm.nih.gov/pubmed/31839144
http://dx.doi.org/10.1016/S2214-109X(19)30453-X

Ejemplares similares